On July 17, 2025, the FDA convened a landmark panel of leading physicians, researchers, and women’s health advocates to reexamine a subject that affects millions: Hormone Replacement
This is the second installment in our blog series supporting Men’s Health Month. Part 1 highlighted the often-overlooked area of care: preventative health and wellness for men.
In today’s healthcare environment, precision and personalization are no longer luxuries—they’re expectations. Yet despite the increasing demand for customized compounded sterile preparations, many people, including
As healthcare providers increasingly turn to 503B outsourcing facilities for sterile compounded preparations, understanding licensing beyond the federal baseline is critical. A facility may be
Healthcare is shifting in a big way. Instead of “one-size-fits-all” treatments, healthcare providers are increasingly focusing on personalized medicine—care tailored to each patient’s unique biology,
When it comes to compounded preparations, healthcare providers and patients alike want assurance that every treatment remains safe, effective, and reliable—from the first dose to
ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced a major expansion of its operations with the addition of new clean rooms,
ProRx Pharma, the leading health and wellness 503B outsourcing facility, announced today it has been awarded a DEA Controlled Substances Registration Certificate, authorizing the company
ProRx confirms that it underwent a routine inspection, Sept. 9 – 19, 2025 by the U.S. Food and Drug Administration (FDA) of its registered 503B
As the nation celebrates National Wellness Month, ProRx, the leading health and wellness 503B outsourcing facility, is spotlighting the importance of safe, personalized pharmaceutical solutions
